1491158-62-3
1491158-62-3
Chemical Structure
Fmoc-Lys(Pal-Glu-OtBu)-OH
- CAS No.: 1491158-62-3
- Formula:C46H69N3O8
- Molecular Weight:792.06
IUPAC Name: N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-((S)-5-(tert-butoxy)-5-oxo-4-palmitamidopentanoyl)-L-lysine
InChIKey: LQQXBYSAGYOQJW-ZAQUEYBZSA-N
SMILES: CCCCCCCCCCCCCCCC(N[C@H](C(OC(C)(C)C)=O)CCC(NCCCC[C@H](NC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)C(O)=O)=O)=O
Biological Activity: Fmoc-Lys(Pal-Glu-OtBu)-OH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Lys(Pal-Glu-OtBu)-OH is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Fmoc-Lys(Pal-Glu-OtBu)-OH | 99.93% | Fmoc-Lys(Pal-Glu-OtBu)-OH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Lys(Pal-Glu-OtBu)-OH is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-Lys[Octa(OtBu)-Glu-OtBu]-OH | Fmoc-Lys[Octa(OtBu)-Glu-OtBu]-OH is an Fmoc-protected amino acid derivative. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-L-Lys(Boc-AEEA-AEEA)-OH | Fmoc-L-Lys(Boc-AEEA-AEEA)-OH is the derivative of AEEA-AEEA (HY-W125504). AEEA-AEEA is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). AEEA-AEEA is also an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-L-Lys (Boc)-OH | 99.94% | Fmoc-L-Lys (Boc)-OH is a lysine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-L-Lys (Boc)-OH-15N2 | Fmoc-L-Lys (Boc)-OH-15N2 is a 15N-labeled Fmoc-L-Lys (Boc)-OH (HY-79128). Fmoc-L-Lys (Boc)-OH is a lysine derivative. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-L-Lys (Boc)-OH-13C | Fmoc-L-Lys (Boc)-OH-13C (Fmoc-L-Lys(Boc)-OH-13C) is 13C labeled Fmoc-L-Lys (Boc)-OH. Fmoc-L-Lys (Boc)-OH is a lysine derivative. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH | 99.31% | Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH is a drug intermediate in the synthesis of Tirzepatide. Tirzepatide is a dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor (GLP-1R) agonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-Lys(Palmitoyl)-OH | 98.90% | Fmoc-Lys(Palmitoyl)-OH is a Fmoc-amino acid with long alkyl chains. Fmoc-Lys(Palmitoyl)-OH can be used for peptide synthesis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-Asu(OtBu)-OH | Fmoc-Asu(OtBu)-OH is a peptide intermediate and can be used in peptide synthesis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-hLys(Boc)-OH | 99.52% | Fmoc-hLys(Boc)-OH is a lysine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH | 99.31% | Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH is an L-Lys (an amino acid) derivative. Fmoc protects amino acids, ensuring their accurate peptide synthesis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
